Clinical Trial Update: A Study of ND0801 in Attention Deficit/Hyperactivity Disorder (ADHD) [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for ND0801 in ADHD across Phase 1 and Phase 2, study is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• ND0801

Snippet

Sponsor: NeuroDerm Ltd. | Conditions: Attention Deficit and Hyperactivity Disorder | Phase 1, Phase 2 | Status: COMPLETED